Gastroenterology CE Activities

Explore how the IBD CDST can help you with treatment selection.

Non-accredited

Empowering Community GIs and Advanced Practitioners: Tools to Enhance Access to IBD Care for the Underserved

0.5 CE Credit(s)

Gastroenterology blog

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.

Gastroenterology
Blog

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.

Gastroenterology
Blog

RMEI Presentations

Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease (ACG)

An Inflammatory Bowel Disease (IBD) Decision Support Tool Predicts Drug Specific Remission and Improves Provider Mastery in Treatment Selection

Multi-Year Education Facilitated the Clinical Implementation of a Novel Point-of-Care Tool

How Education Facilitated Uptake of a Novel Point of Care Decision Aid in IBD: The IBD Clinical Decision Support Tool

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

When the Patient Voice is Heard in Education, Does the Clinician Listen?

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

The Gastroenterology Learner Pathway in IBD: An Outcomes-Based Iterative Approach to IBD Education Using Advanced Analytics and Predictive Modeling to Sustain Behavioral Change

LATEST Gastroentrology ARTICLES

Latest Gastroentrology Articles

A Major Step toward a Cure for Hepatitis B Infection June 25, 2026
The current treatment of chronic hepatitis B infection includes nucleoside or nucleotide analogue (NA) therapy and pegylated interferon. Both of these treatments are effective in suppressing hepatitis B virus (HBV) replication and in reducing the risk of cirrhosis and hepatocellular carcinoma.1 However, these treatments do not eradicate HBV,...
Anna S. Lok
Prevention and Treatment of Peanut Allergy June 25, 2026
Peanuts should be introduced at 4 to 6 months of age in infants at high risk for allergy and at approximately 6 months of age in other infants. For infants with peanut allergy, early immunotherapy is safer and more effective.
George Du Toit, Gideon Lack
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection June 25, 2026
In two phase 3 trials, 19% of patients with chronic hepatitis B infection had a functional cure with the antisense oligonucleotide bepirovirsen, 24 weeks after stopping all HBV treatment; functional cure was not seen with placebo.
Jinlin Hou, Seng-Gee Lim, Maria Buti, Man-Fung Yuen, Edward Gane, Pietro Lampertico, Norah Terrault, Huy Nguyen, Hyung Joon Yim, Qing Xie, Jianmei Lin, Yunqing Qiu, Wen-Juei Jeng, Jeong Heo, Cheng-Yuan Peng, Chien-Hung Chen, Wan-Long Chuang, Yao Xie, Maria Hlebowicz, Nevin Idriz, Rajiv Mehta, Kosh Agarwal, Monica M. Gomes da Silva, Alex Franca, Roxana Cernat, Apinya Leerapun, Carla S. Coffin, Adrian Gadano, Pietro Andreone, Shigetoshi Fujiyama, Vasileios Sevastianos, Yuichiro Suzuki, Vlad Ratziu, Ghassan Riachi, Hartmut Stocker, Tien Huey Lim, Tarik Asselah, Yasuhito Tanaka, Jacinta Holmes, Xieer Liang, Jennifer Cremer, Tamara Lukić, Helene Plein, Geoff Quinn, Yu Tao, Melanie Paff, Dickens Theodore, Robert Elston, the B-Well Study Group*

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.